good news! Free anti-cancer new drug fumaric acid BGB-10188 capsule clinical trial! No tumor type

Cancer patients hope to receive effective treatment, but some patients cannot receive surgery or radiotherapy due to their frailty, Chemotherapy, if you have such patients around you, you can pay attention to this new anti-cancer drug Fumaric Acid BGB-10188 Capsule< /strong>Clinical project,Registration number CTR20220463.

Indications: small lymphocytic lymphoma, follicular lymphoma, marginal zone lymphoma, chronic lymphocytic leukemia, diffuse large B Cell lymphoma, as well as non-small cell lung cancer, small cell lung cancer, metastatic melanoma, etc.

Physician profile: Liu Peng, male, professor, chief physician, director of the Department of Hematology, Zhongshan Hospital Affiliated to Fudan University. Chairman of Lymphoma Special Committee of Shanghai Cancer Prevention and Treatment Alliance, Vice Chairman of Hematological Oncology Special Committee of Shanghai Anti-Cancer Association, member of Hematological Oncology Special Committee of China Anti-Cancer Association. Specializes in the diagnosis and treatment of multiple myeloma, lymphoma, and chronic lymphocytic leukemia

Currently, domestic hospitals carrying out this clinical drug research include West China Hospital of Sichuan University and the Second Affiliated Hospital of Zhejiang University School of Medicine , the First Affiliated Hospital of Soochow University, and the Third Xiangya Hospital of Central South University, no fee will be charged after enrollment, if you have any questions, please leave a message and ask me:

  • < span>Patients who cannot swallow capsules or suffer from diseases affecting gastrointestinal function;
  • Patients with hepatitis B, hepatitis C, acquired immunodeficiency syndrome
  • Patients have severe cardiovascular and cerebrovascular diseases; have a history of severe bleeding disorders, such as hemophilia A, hemophilia B, von Willebrand;
  • Patients have undergone organ transplantation;
  • The goal is to enroll 50 people, and two people have been successfully enrolled, and the number of places is limited. If you need it, please apply as soon as possible , Please forward it to patients in need if you don’t need it.